Paul Tudor Jones’s BioNTech BNTX Stock Holding History

Paul Tudor Jones’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.24M	Buy	+13,300	New	+$1.25M	﹤0.01%	2255
2025 Q4	–	Sell	-19,200	Closed	-$1.89M	–	3516
2025 Q3	$1.89M	Buy	19,200 +13,800	+256%	+$1.48M	﹤0.01%	1840
2025 Q2	$575K	Buy	+5,400	New	+$545K	﹤0.01%	2506
2025 Q1	–	Sell	-5,600	Closed	-$638K	–	3079
2024 Q4	$638K	Sell	5,600 -500	-8%	-$57.1K	﹤0.01%	2049
2024 Q3	$724K	Buy	+6,100	New	+$561K	﹤0.01%	1815

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Paul Tudor Jones's BNTX Position: Q2 2026 in Review

Paul Tudor Jones sold out of BioNTech (BNTX) in Q2 2026, closing a stake of 7,758 shares — an estimated $730K sold.

Paul Tudor Jones first reported a position in BNTX in Q1 2021 and held it in 7 quarters. The position peaked at $770K in Q4 2022. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Paul Tudor Jones reported no remaining BioNTech position as of Q2 2026 after selling out during the quarter.
Paul Tudor Jones sold 7,758 BioNTech shares in Q2 2026, an estimated $730K.
Paul Tudor Jones first reported a position in BioNTech in Q1 2021 and held it in 7 quarters.
Paul Tudor Jones's BioNTech position peaked at $770K in Q4 2022.
281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.